Skip to Content

Monsanto Roundup Lawsuit

Monsanto Roundup Lawsuit

Roundup’s Lethal Consequences

Monsanto, a biochemical subsidiary of the pharmaceutical company Bayer, sells the world’s most commonly-used herbicide: Roundup. Recently, glyphosate, a toxic active ingredient in Roundup has led to a series of investigations and lawsuits. According to the International Agency for Research on Cancer, which is part of the World Health Organization, glyphosate has been deemed a probable cause of cancer.

In fact, studies show that prostate cancer is more prevalent in communities with high use of Roundup. Research also links breast cancer to Roundup, because increased exposure to glyphosate can lead to mammary tumors. Furthermore, studies indicate a relationship between Roundup and brain cancer, because parental exposure to glyphosate two years prior to a child’s birth can significantly increase the risk of the child developing brain cancer. Moreover, people with the highest exposure to glyphosate have a 41% higher risk of developing non-Hodgkin lymphoma, a type of blood cancer.

As a result, over 13,000 plaintiffs, all of whom are Roundup-induced cancer victims or related to these victims, filed suit against Monsanto. The plaintiffs allege Monsanto engaged in a variety of duplicitous strategies to conceal the dangers of its herbicide, including conspiring with regulatory agencies, falsifying scientific research with ghostwritten studies, and employing outside entities to advertise the safety of Roundup while ensuring these organizations and individuals falsely seemed to be acting independently of Monsanto. Out of these thousands of cases, so far three cases, all of which took place in California, resulted in verdict total upwards of $2.21 billion.

We’re Here to Help

As the litigation proceeds, investors in Bayer, which owns Monsanto, have grown more restless and many are pushing Bayer to seriously consider a global settlement. Such a settlement would be incredibly costly, with several experts estimating the number could range from $2 billion to $3 billion at best, and up to $10 billion at worst. With the stocks of Bayer reaching a 7-year low after the company was forced to award $2 billion to a couple who had contracted Non-Hodgkin Lymphoma, the biochemical giant has begun seeking alternatives for glyphosate in an effort to rebuild its image with consumers. Our team at Oppenheim Law recognizes the emotional burden these illnesses can have on families. That’s why our firm is committed to representing our clients, providing the best team of professionals to represent them.

If you or a loved one has been exposed to Roundup either directly or indirectly and have unfortunately developed Non-Hodgkin Lymphoma or other related cancers, you may be entitled to financial compensation. Please feel free to contact us at (954) 384-6114 so we can inform you of your legal rights so you can obtain the compensation to which you are entitled.


From the Trenches,

Roy Oppenheim

Tags: Edwin Hardeman, glyphosate, Monsanto, Non-Hodgkin Lymphoma, Roundup, Sonoma County, Monsanto roundup lawsuit attorneys